Paolo Arosio

Q: What Schools Are Affiliated With Paolo Arosio

Paolo Arosio is affiliated with the following schools: University of Milan, ETH Zurich, University of Pavia, University of Brescia, University of Zurich, University of Cambridge, Polytechnic University of Milan

Paolo Arosio's AcademicInfluence.com Rankings

Paolo Arosio

Computer Science

#4162

World Rank

#4378

Historical Rank

Computational Linguistics

#349

World Rank

#354

Historical Rank

Machine Learning

#734

World Rank

#744

Historical Rank

Artificial Intelligence

#939

World Rank

#956

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Paolo Arosio's Degrees

PhD Computer Science University of Milan
Masters Computer Science University of Milan
Bachelors Computer Science University of Milan

Similar Degrees You Can Earn

Why Is Paolo Arosio Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paolo Arosio's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The ferritins: molecular properties, iron storage function and cellular regulation. (1996) (2449)
Ferritins: a family of molecules for iron storage, antioxidation and more. (2009) (724)
Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts (1991) (638)
Ferritin, iron homeostasis, and oxidative damage. (2002) (488)
On the lag phase in amyloid fibril formation (2015) (478)
Molecular mechanisms of protein aggregation from global fitting of kinetic models (2016) (430)
Self-assembling peptide and protein amyloids: from structure to tailored function in nanotechnology. (2017) (422)
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. (2004) (391)
On ferritin heterogeneity. Further evidence for heteropolymers. (1978) (387)
A Human Mitochondrial Ferritin Encoded by an Intronless Gene* (2001) (369)
A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains (1995) (328)
Mechanism of ferritin iron uptake: activity of the H-chain and deletion mapping of the ferro-oxidase site. A study of iron uptake and ferro-oxidase activity of human liver, recombinant H-chain ferritins, and of two H-chain deletion mutants. (1988) (316)
Structure, function, and evolution of ferritins. (1992) (289)
Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. (2010) (269)
Identification of the ferroxidase centre in ferritin (1989) (265)
The molecular chaperone Brichos breaks the catalytic cycle that generates toxic Aβ oligomers (2015) (261)
Early Embryonic Lethality of H Ferritin Gene Deletion in Mice* (2000) (256)
Iron Homeostasis in Health and Disease (2016) (250)
Evidence of H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin. (1992) (243)
Overexpression of Wild Type and Mutated Human Ferritin H-chain in HeLa Cells (2000) (239)
New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. (2008) (237)
Water-dispersible sugar-coated iron oxide nanoparticles. An evaluation of their relaxometric and magnetic hyperthermia properties. (2011) (231)
Ferritin functions as a proinflammatory cytokine via iron‐independent protein kinase C zeta/nuclear factor kappaB–regulated signaling in rat hepatic stellate cells (2009) (230)
The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation. (2014) (217)
Ferritin, cellular iron storage and regulation (2017) (206)
Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. (2003) (203)
Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation (2016) (187)
Chemical kinetics for drug discovery to combat protein aggregation diseases. (2014) (181)
Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects. (1990) (177)
The role of the L-chain in ferritin iron incorporation. Studies of homo and heteropolymers. (1994) (171)
Mitochondrial ferritin: a new player in iron metabolism. (2002) (170)
Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer’s disease (2016) (167)
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer’s disease (2016) (165)
RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload. (2007) (152)
Human Mitochondrial Ferritin Expressed in HeLa Cells Incorporates Iron and Affects Cellular Iron Metabolism* (2002) (147)
Reconstitution of manganese oxide cores in horse spleen and recombinant ferritins. (1995) (147)
Multiple pathways for mineral core formation in mammalian apoferritin. The role of hydrogen peroxide. (2003) (144)
Production and characterization of recombinant heteropolymers of human ferritin H and L chains. (1993) (142)
Mitochondrial Ferritin Expression in Adult Mouse Tissues (2007) (141)
Influence of site-directed modifications on the formation of iron cores in ferritin. (1991) (141)
Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury. (2013) (141)
Dysregulation of Iron Homeostasis in the CNS Contributes to Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis (2009) (139)
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo. (2011) (138)
Biofortification for combating 'hidden hunger' for iron. (2012) (137)
Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide (2020) (136)
Interaction of the Molecular Chaperone DNAJB6 with Growing Amyloid-beta 42 (Aβ42) Aggregates Leads to Sub-stoichiometric Inhibition of Amyloid Formation* (2014) (133)
The S/T-Rich Motif in the DNAJB6 Chaperone Delays Polyglutamine Aggregation and the Onset of Disease in a Mouse Model. (2016) (132)
Biology of ferritin in mammals: an update on iron storage, oxidative damage and neurodegeneration (2014) (132)
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome (2006) (128)
Ferritin as an important player in neurodegeneration. (2011) (127)
Ferritin ferroxidase activity: A potent inhibitor of osteogenesis (2010) (127)
Evidence that the specificity of iron incorporation into homopolymers of human ferritin L- and H-chains is conferred by the nucleation and ferroxidase centres. (1996) (123)
Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma. (2003) (121)
Reaction paths of iron oxidation and hydrolysis in horse spleen and recombinant human ferritins. (1998) (120)
Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: evidence for a proliferative role of L-ferritin. (2004) (120)
Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. (2002) (120)
Human isoferritins in normal and disease states. (1977) (119)
Evidence that a salt bridge in the light chain contributes to the physical stability difference between heavy and light human ferritins. (1992) (116)
The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast. (2004) (114)
Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3) (2002) (113)
Crystal structure and biochemical properties of the human mitochondrial ferritin and its mutant Ser144Ala. (2004) (111)
Hepcidin antagonists for potential treatments of disorders with hepcidin excess (2014) (109)
Quantification of the concentration of Aβ42 propagons during the lag phase by an amyloid chain reaction assay. (2014) (109)
Expression and structural and functional properties of human ferritin L-chain from Escherichia coli. (1989) (108)
Multifunctional nanoparticles for dual imaging. (2011) (107)
Immunologic differences in human isoferritins: implications for immunologic quantitation of serum ferritin. (1977) (106)
Identification of the EPR-active iron-nitrosyl complexes in mammalian ferritins. (1994) (100)
Multiple mechanisms of iron-induced ferritin synthesis in HeLa cells. (1985) (100)
Characterization of Serum Ferritin in Iron Overload: Possible Identity to Natural Apoferritin (1977) (99)
Structural and immunological relationships of isoferritins in normal and malignant cells. (1976) (99)
Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates (2019) (98)
Facilitated diffusion of iron(II) and dioxygen substrates into human H-chain ferritin. A fluorescence and absorbance study employing the ferroxidase center substitution Y34W. (2008) (97)
Aggregation Mechanism of an IgG2 and two IgG1 Monoclonal Antibodies at low pH: From Oligomers to Larger Aggregates (2013) (95)
Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method (2017) (95)
Mitochondrial ferritin. (2004) (94)
Functional and immunological analysis of recombinant mouse H- and L-ferritins from Escherichia coli. (2000) (94)
Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies. (1986) (91)
Mutational analysis of the channel and loop sequences of human ferritin H-chain. (1989) (91)
Unique iron binding and oxidation properties of human mitochondrial ferritin: a comparative analysis with Human H-chain ferritin. (2005) (90)
Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. (2007) (90)
The X-ray three-dimensional structure of avidin. (1999) (89)
Evidence that residues exposed on the three-fold channels have active roles in the mechanism of ferritin iron incorporation. (1996) (89)
Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. (2003) (88)
Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA. (1997) (88)
Chemical–Physical Changes in Cell Membrane Microdomains of Breast Cancer Cells After Omega-3 PUFA Incorporation (2012) (88)
Hereditary Hyperferritinemia-Cataract Syndrome: Relationship Between Phenotypes and Specific Mutations in the Iron-Responsive Element of Ferritin Light-Chain mRNA (1997) (86)
Microfluidic Diffusion Analysis of the Sizes and Interactions of Proteins under Native Solution Conditions. (2016) (84)
Iron(II) and hydrogen peroxide detoxification by human H-chain ferritin. An EPR spin-trapping study. (2006) (84)
Aggregation Stability of a Monoclonal Antibody During Downstream Processing (2011) (83)
Characterization and Distribution of Ferritin Binding Sites in the Adult Mouse Brain (1999) (83)
Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation. (2005) (82)
Origin of the unusual kinetics of iron deposition in human H-chain ferritin. (2005) (80)
Ferroxidase kinetics of human liver apoferritin, recombinant H-chain apoferritin, and site-directed mutants. (1993) (79)
Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. (2009) (78)
mu-1,2-Peroxobridged di-iron(III) dimer formation in human H-chain ferritin. (2002) (77)
Mutated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo: a link between ferritin ferroxidase activity and biological function. (1991) (77)
Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation (2010) (76)
Population balance modeling of antibodies aggregation kinetics. (2012) (76)
Analysis of Ferritins in Lymphoblastoid Cell Lines and in the Lens of Subjects With Hereditary Hyperferritinemia-Cataract Syndrome (1998) (76)
Coexistence of plasmonic and magnetic properties in Au89Fe11 nanoalloys. (2013) (76)
Overexpression of the hereditary hemochromatosis protein, HFE, in HeLa cells induces an iron‐deficient phenotype (1999) (76)
Iron detoxifying activity of ferritin (1990) (74)
Mitochondrial Ferritin in the Substantia Nigra in Restless Legs Syndrome (2009) (74)
Macrophage and epithelial cell H-ferritin expression regulates renal inflammation (2015) (74)
Structural Ensembles of Membrane-bound α-Synuclein Reveal the Molecular Determinants of Synaptic Vesicle Affinity (2016) (74)
Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control. (1991) (71)
Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy (2010) (70)
The influence of purified recombinant human heavy-subunit and light-subunit ferritins on colony formation in vitro by granulocyte-macrophage and erythroid progenitor cells. (1986) (69)
Structural description of the active sites of mouse L-chain ferritin at 1.2 Å resolution (2002) (69)
Role of iron and ferritin in TNFα‐induced apoptosis in HeLa cells (2003) (68)
On the role of salt type and concentration on the stability behavior of a monoclonal antibody solution. (2012) (68)
Ferrous ion binding to recombinant human H-chain ferritin. An isothermal titration calorimetry study. (2002) (68)
The importance of eukaryotic ferritins in iron handling and cytoprotection. (2015) (67)
Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. (2014) (67)
Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. (2007) (67)
Human serum ferritin G‐peptide is recognized by anti‐L ferritin subunit antibodies and concanavalin‐A (1987) (66)
Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth. (1991) (65)
Immunosuppressive effects of melanoma‐derived heavy‐chain ferritin are dependent on stimulation of IL‐10 production (2001) (65)
Biologic and clinical significance of red cell ferritin. (1983) (64)
Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. (2004) (63)
Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis. (1989) (63)
Functional roles of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells. (1992) (63)
Magnetic, optical and relaxometric properties of organically coated gold–magnetite (Au–Fe3O4) hybrid nanoparticles for potential use in biomedical applications (2012) (62)
Denatured H-ferritin subunit is a major constituent of haemosiderin in the liver of patients with iron overload (2002) (61)
Structural heterogeneity and subunit composition of horse ferritins. (1982) (61)
Relationship between TNF‐α and iron metabolism in differentiating human monocytic THP‐1 cells (2000) (60)
The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin. (2008) (60)
Structure and morphology of HDPE-g-MA/organoclay nanocomposites: Effects of the preparation procedures (2008) (57)
A new model of resorbable device degradation and drug release: transient 1-dimension diffusional model. (2009) (57)
An immunoglobulin-like fold in a major plant allergen: the solution structure of Phl p 2 from timothy grass pollen. (1999) (55)
Is hydrogen peroxide produced during iron(II) oxidation in mammalian apoferritins? (2001) (55)
Molecular diffusion into ferritin: pathways, temperature dependence, incubation time, and concentration effects. (2000) (54)
Scalable Production and Isolation of Extracellular Vesicles: Available Sources and Lessons from Current Industrial Bioprocesses (2019) (54)
Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation (2015) (54)
ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control. (2007) (53)
Machine Learning for Biologics: Opportunities for Protein Engineering, Developability, and Formulation (2021) (53)
Hybrid iron oxide-copolymer micelles and vesicles as contrast agents for MRI: impact of the nanostructure on the relaxometric properties. (2013) (53)
Characterization of human ferritin H chain synthetized in Escherichia coli. (1987) (53)
Ferritin Light Chain Confers Protection Against Sepsis-Induced Inflammation and Organ Injury (2019) (52)
Production of a soluble and functional recombinant streptavidin in Escherichia coli. (1998) (52)
Mutant Ferritin L-chains That Cause Neurodegeneration Act in a Dominant-negative Manner to Reduce Ferritin Iron Incorporation* (2010) (52)
Characteristics and expression of binding sites specific for ferritin H-chain on human cell lines. (1988) (51)
A multiscale view of therapeutic protein aggregation: A colloid science perspective (2015) (51)
Latent analysis of unmodified biomolecules and their complexes in solution with attomole detection sensitivity. (2015) (49)
Water-soluble rhamnose-coated Fe3O4 nanoparticles. (2009) (47)
Effects of modifications near the 2-, 3- and 4-fold symmetry axes on human ferritin renaturation. (1997) (46)
Hadron Therapy, Magnetic Nanoparticles and Hyperthermia: A Promising Combined Tool for Pancreatic Cancer Treatment (2020) (46)
Transient overexpression of human H- and L-ferritin chains in COS cells. (1998) (46)
Design of water-based ferrofluids as contrast agents for magnetic resonance imaging. (2011) (46)
On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging. (2018) (46)
Inhibition of α-Synuclein Fibril Elongation by Hsp70 Is Governed by a Kinetic Binding Competition between α-Synuclein Species. (2017) (45)
The putative "nucleation site" in human H-chain ferritin is not required for mineralization of the iron core. (2004) (45)
Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication (2017) (45)
Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation (2010) (45)
End-to-end self-assembly of RADA 16-I nanofibrils in aqueous solutions. (2012) (44)
Role of Zn2+ Substitution on the Magnetic, Hyperthermic, and Relaxometric Properties of Cobalt Ferrite Nanoparticles (2019) (44)
Mechanistic Origin of the Combined Effect of Surfaces and Mechanical Agitation on Amyloid Formation. (2017) (44)
Kinetic analysis of the multistep aggregation mechanism of monoclonal antibodies. (2014) (44)
Structure of nanotubular titanium oxide templates prepared by electrochemical anodization in H2SO4/HF solutions (2007) (44)
Defining metal ion inhibitor interactions with recombinant human H- and L-chain ferritins and site-directed variants: an isothermal titration calorimetry study (2003) (44)
Ordered Stacking of Regioregular Head-to-Tail Polyalkylthiophenes: Insights from the Crystal Structure of Form I′ Poly(3-n-butylthiophene) (2009) (44)
Iron release from ferritin by flavin nucleotides. (2013) (43)
The insertion torque‐depth curve integral as a measure of implant primary stability: An in vitro study on polyurethane foam blocks (2017) (42)
Multiple subunits in human ferritins: evidence for hybrid molecules. (1975) (42)
Microelectronic DNA chip for hereditary hyperferritinemia cataract syndrome, a model for large‐scale analysis of disorders of iron metabolism (2006) (42)
Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity (2014) (42)
New TFR2 mutations in young Italian patients with hemochromatosis (2008) (41)
Atomic force microscopy imaging of lipid rafts of human breast cancer cells. (2012) (41)
NCOA4-mediated ferritinophagy promotes ferroptosis induced by erastin, but not by RSL3 in HeLa cells. (2020) (41)
Expression and characterization of the ferritin binding domain of Nuclear Receptor Coactivator-4 (NCOA4). (2017) (41)
Biochemical characterization and crystal structure of a recombinant hen avidin and its acidic mutant expressed in Escherichia coli. (1998) (40)
Dynamics of protein aggregation and oligomer formation governed by secondary nucleation. (2015) (40)
Pat1 promotes processing body assembly by enhancing the phase separation of the DEAD-box ATPase Dhh1 and RNA (2018) (40)
Microfluidics for Protein Biophysics. (2017) (39)
Structural and functional studies of human ferritin H and L chains. (1991) (39)
Iron Oxidation and Core Formation in Recombinant Heteropolymeric Human Ferritins. (2017) (39)
Double-gradient denaturing gradient gel electrophoresis assay for identification of L-ferritin iron-responsive element mutations responsible for hereditary hyperferritinemia-cataract syndrome: identification of the new mutation C14G. (2001) (38)
Dynamics of synthetic membraneless organelles in microfluidic droplets. (2019) (38)
Case report: a subject with a mutation in the ATG start codon of L-ferritin has no haematological or neurological symptoms (2004) (38)
Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo. (2014) (37)
Characteristics of a ferritin‐binding protein present in human serum (1987) (37)
Scanning mutations of the 5′UTR regulatory sequence of l‐ferritin by denaturing high‐performance liquid chromatography: identification of new mutations (2003) (37)
Development of a monoclonal antibody against human heart ferritin and its application in an immunoradiometric assay. (1983) (37)
Time evolution of amyloid fibril length distribution described by a population balance model (2012) (37)
Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder (2006) (36)
Multifunctional Protein Materials and Microreactors using Low Complexity Domains as Molecular Adhesives. (2018) (36)
Density-gradient-free microfluidic centrifugation for analytical and preparative separation of nanoparticles. (2014) (36)
A new model of resorbable device degradation and drug release - part I: zero order model (2008) (36)
Analysis of ferritins in lymphoblastoid cell lines and in the lens of subjects with hereditary hyperferritinemia-cataract syndrome. (1998) (35)
Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells. (2000) (34)
Construction of a ferroxidase center in human ferritin L-chain. (1994) (34)
International collaborative study to evaluate a recombinant L ferritin preparation as an International Standard. (1997) (33)
Conserved S/T Residues of the Human Chaperone DNAJB6 Are Required for Effective Inhibition of Aβ42 Amyloid Fibril Formation. (2018) (33)
Effect of acidic and basic isoferritins on in vitro growth of human granulocyte-monocyte progenitors. (1986) (33)
Role of iron and ferritin in TNFalpha-induced apoptosis in HeLa cells. (2003) (33)
Microfluidic Approaches for the Characterization of Therapeutic Proteins. (2018) (32)
Ferritin—a mediator of apoptosis? (2007) (32)
Ferroportin gene silencing induces iron retention and enhances ferritin synthesis in human macrophages (2004) (32)
Superparamagnetic iron oxide nanoparticles functionalized by peptide nucleic acids (2017) (32)
Vanadyl(IV) binding to mammalian ferritins. An EPR study aided by site-directed mutagenesis. (2000) (32)
Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis (1989) (32)
Development of an immunoassay for all human isoferritins, and its application to serum ferritin evaluation. (1989) (32)
Iron Acquisition in Bacillus cereus: The Roles of IlsA and Bacillibactin in Exogenous Ferritin Iron Mobilization (2014) (32)
Biochemical and immunological characterization of recombinant allergen Lol p 1. (1997) (32)
Characterization of magnetic nanoparticles from Magnetospirillum Gryphiswaldense as potential theranostics tools. (2016) (31)
Biochemical and genetic defects underlying human congenital hypotransferrinemia. (2000) (31)
Tyrosyl radical formation during the oxidative deposition of iron in human apoferritin. (1995) (31)
Characterization of the ferritin receptors of human T lymphoid (MOLT-4) cells. (1992) (31)
Magnetic and relaxation properties of multifunctional polymer‐based nanostructured bioferrofluids as MRI contrast agents (2011) (30)
Redox reactivity of animal apoferritins and apoheteropolymers assembled from recombinant heavy and light human chain ferritins. (1999) (29)
A novel deletion of the l‐ferritin iron‐responsive element responsible for severe hereditary hyperferritinaemia–cataract syndrome (2002) (29)
Immunological Reactivity of Serum Ferritin in Patients with Malignancy (1985) (29)
Acceleration of an Enzymatic Reaction in Liquid Phase Separated Compartments Based on Intrinsically Disordered Protein Domains (2020) (28)
Distinct stability of recombinant L and H subunits of human ferritin: calorimetric and ANS binding studies. (1998) (28)
Recombinant human hepcidin expressed in Escherichia coli isolates as an iron containing protein. (2005) (28)
Identification of two novel mutations in the 5'-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning. (2003) (28)
Synthesis, Characterization, and Crystalline Structure of Syndiotactic 1,2-Polypentadiene: The Trans Polymer (2005) (28)
The importance of iron in pathophysiologic conditions (2015) (28)
Correlation between the bone density recorded by a computerized implant motor and by a histomorphometric analysis: a preliminary in vitro study on bovine ribs. (2015) (28)
Cell Membrane‐Coated Magnetic Nanocubes with a Homotypic Targeting Ability Increase Intracellular Temperature due to ROS Scavenging and Act as a Versatile Theranostic System for Glioblastoma Multiforme (2019) (27)
A comparative Mössbauer study of the mineral cores of human H-chain ferritin employing dioxygen and hydrogen peroxide as iron oxidants. (2007) (27)
Immunocytochemical detection of ferritin in human bone marrow and peripheral blood cells using monoclonal antibodies specific for the H and L subunit (1990) (27)
Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells (2015) (27)
Synergistic effects of flow and interfaces on antibody aggregation (2020) (27)
Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis. (1989) (27)
Deficient ferritin immunoreactivity in tissues from niemann-pick type C patients: extension of findings to fetal tissues, H and L ferritin isoforms, but also one case of the rare Niemann-Pick C2 complementation group. (2000) (26)
The role of surfaces on amyloid formation. (2021) (26)
Antiferritin single-chain Fv fragment is a functional protein with properties of a partially structured state: comparison with the completely folded V(L) domain. (2000) (26)
Iron incorporation into ferritins: evidence for the transfer of monomeric Fe(III) between ferritin molecules and for the formation of an unusual mineral in the ferritin of Escherichia coli. (1994) (26)
Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors (2020) (26)
The sedimentation properties of ferritins. New insights and analysis of methods of nanoparticle preparation. (2010) (26)
Fusion of the antiferritin antibody VL domain to barnase results in enhanced solubility and altered pH stability. (2004) (25)
HFE gene mutations in a population of Italian Parkinson's disease patients. (2008) (25)
Effect of polyol sugars on the stabilization of monoclonal antibodies. (2015) (25)
Microfluidic Diffusion Viscometer for Rapid Analysis of Complex Solutions. (2016) (24)
Mutations of ferritin H chain C-terminus produced by nucleotide insertions have altered stability and functional properties. (2006) (24)
Identification of H‐ and L‐ferritin subunit binding sites on human T and B lymphoid cells (1989) (24)
Microfluidic Shrinking Droplet Concentrator for Analyte Detection and Phase Separation of Protein Solutions. (2020) (24)
Solubilization from spinach thylakoids of a higher molecular weight form of ferredoxin‐NADP+ reductase (1980) (24)
Fluorescent and paramagnetic core–shell hybrid nanoparticles for bi-modal magnetic resonance/luminescence imaging (2012) (24)
Correlation between Implant Geometry, Bone Density, and the Insertion Torque/Depth Integral: A Study on Bovine Ribs (2019) (23)
Nanoalgosomes: Introducing extracellular vesicles produced by microalgae (2021) (23)
Analysis of ferritin genes in Parkinson disease. (2007) (23)
Biodegradable zwitterionic nanoparticles with tunable UCST-type phase separation under physiological conditions. (2019) (23)
Mechanisms of regulation of ferritin synthesis in rat liver during experimental inflammation. (1988) (23)
Potential Role of H-Ferritin in Mitigating Valvular Mineralization (2019) (23)
Use of a monoclonal antibody against human heart ferritin for evaluating acidic ferritin concentration in human serum (1985) (23)
Human recombinant antibody fragments specific for a rye-grass pollen allergen: characterization and potential applications. (1996) (22)
Stability and gelation behavior of bovine serum albumin pre-aggregates in the presence of calcium chloride. (2012) (21)
Blotting analysis of native IRP1: a novel approach to distinguish the different forms of IRP1 in cells and tissues. (2004) (21)
Study of ferritin self-assembly and heteropolymer formation by the use of Fluorescence Resonance Energy Transfer (FRET) technology. (2017) (21)
A mutational analysis of the epitopes of recombinant human H-ferritin. (1990) (21)
Ferritin in the red cells of normal subjects and patients with iron deficiency and iron overload (1983) (21)
Comparative study between Hfe‐/‐ and β2m‐/‐ mice: progression with age of iron status and liver pathology (2006) (21)
Distribution of Trabecular Bone Density in the Maxilla and Mandible. (2019) (21)
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis. (2021) (21)
Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation (2018) (21)
In-vitro and in-vivo characterization of CRANAD-2 for multi-spectral optoacoustic tomography and fluorescence imaging of amyloid-beta deposits in Alzheimer mice (2020) (21)
Kinetic studies of iron deposition catalyzed by recombinant human liver heavy and light ferritins and Azotobacter vinelandii bacterioferritin using O2 and H2O2 as oxidants. (2005) (21)
Characteristics of ferritins in human milk secretions: similarities to serum and tissue isoferritins. (1986) (20)
Ferritins in malignant and non‐malignant lymphoid cells (1986) (20)
Tailoring the magnetic core of organic-coated iron oxides nanoparticles to influence their contrast efficiency for Magnetic Resonance Imaging (2019) (20)
In Vitro Aggregation Behavior of a Non-Amyloidogenic λ Light Chain Dimer Deriving from U266 Multiple Myeloma Cells (2012) (20)
Sol-gel transition of charged fibrils composed of a model amphiphilic peptide. (2015) (20)
The Ferritin-Heavy-Polypeptide-Like-17 (FTHL17) gene encodes a ferritin with low stability and no ferroxidase activity and with a partial nuclear localization. (2015) (20)
Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia (2017) (20)
Role of cosolutes in the aggregation kinetics of monoclonal antibodies. (2014) (20)
Regulation of ferritin synthesis in malignant and non-malignant lymphoid cells. (1986) (20)
Sulfate anion delays the self-assembly of human insulin by modifying the aggregation pathway. (2014) (20)
Characterization of the H- and L-subunit ratios of ferritins by sodium dodecyl sulfate-capillary gel electrophoresis. (2002) (20)
Isolation of extracellular vesicles from microalgae: towards the production of sustainable and natural nanocarriers of bioactive compounds. (2021) (20)
Erythrocyte ferritin in thalassemia syndromes. (1984) (20)
Recombinant allergen Lol p II: expression, purification and characterization. (1995) (20)
Inhibition of heme synthesis alters Amyloid Precursor Protein processing (2008) (19)
α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controls (2019) (19)
NMR-D study of the local spin dynamics and magnetic anisotropy in different nearly monodispersed ferrite nanoparticles (2013) (19)
Mechanistic modelling of avascular tumor growth and pharmacokinetics influence—Part I (2007) (19)
Heparanase Overexpression Reduces Hepcidin Expression, Affects Iron Homeostasis and Alters the Response to Inflammation (2016) (18)
Biophysical approaches for the study of interactions between molecular chaperones and protein aggregates (2015) (18)
In-gel study of the effect of magnetic nanoparticles immobilization on their heating efficiency for application in Magnetic Fluid Hyperthermia (2019) (18)
Serum ferritin evaluation with radioimmunoassays specific for HeLa and liver ferritin types. (1981) (18)
Analysis of biomolecular condensates and protein phase separation with microfluidic technology. (2020) (18)
Behavioral Characterization of Mouse Models of Neuroferritinopathy (2015) (18)
Flow Cytometry Evaluation of Erythroid Dysplasia in Patients with Myelodysplastic Syndrome. (2004) (18)
An accelerated surface-mediated stress assay of antibody instability for developability studies (2020) (18)
Superparamagnetic iron oxide nanoparticles stabilized by a poly(amidoamine)-rhenium complex as potential theranostic probe. (2014) (18)
Synthesis, Characterization and Molecular Conformation of Syndiotactic 1,2 Polypentadiene: The Cis Polymer (2005) (17)
Expression, refolding, and ferritin-binding activity of the isolated VL-domain of monoclonal antibody F11. (2000) (17)
A hydrophobic low-complexity region regulates aggregation of the yeast pyruvate kinase Cdc19 into amyloid-like aggregates in vitro (2018) (17)
Particle-Based Monte-Carlo Simulations of Steady-State Mass Transport at Intermediate Péclet Numbers (2016) (17)
Accelerated Aggregation Studies of Monoclonal Antibodies: Considerations for Storage Stability. (2019) (17)
Structure of mouse L-chain ferritin at 1.6 A resolution. (2001) (17)
Synthesis and structural characterization of syndiotactic trans-1,2 and cis-1,2 polyhexadienes (2007) (17)
Dynamic arrest and aging of biomolecular condensates are modulated by low-complexity domains, RNA and biochemical activity (2021) (17)
On the magnetic anisotropy and nuclear relaxivity effects of Co and Ni doping in iron oxide nanoparticles (2016) (17)
Hybrid Models Based on Machine Learning and an Increasing Degree of Process Knowledge: Application to Capture Chromatographic Step (2021) (17)
Basic and acidic isoferritins in the serum of patients with Hodgkin's disease. (1983) (16)
High Sulfation and a High Molecular Weight Are Important for Anti-hepcidin Activity of Heparin (2016) (16)
Binding and suppressive activity of human recombinant ferritins on erythroid cells (1992) (15)
On Ferritin Heterogeneity (2002) (15)
First detailed determination of the molecular conformation and the crystalline packing of a chiral poly(3-alkylthiophene) : Poly-3-(S)-2-methylbutylthiophene (2007) (15)
Antiferritin single‐chain antibody: a functional protein with incomplete folding? (1998) (15)
Microfluidic Diffusion Analysis of the Size Distribution and Microrheological Properties of Antibody Solutions at High Concentrations (2018) (15)
Denaturing HPLC analysis of DNA deletions and insertions (2003) (15)
Effect of chaotropes on the kinetics of iron release from ferritin by flavin nucleotides. (2017) (15)
Serum ferritin in type I diabetes. (1985) (15)
Methodological effects on the quantitation of serum ferritin by radio- and enzymoimmunoassays. (1982) (14)
A microfluidic platform for quantitative measurements of effective protein charges and single ion binding in solution. (2015) (14)
Evaluation of iron stores in patients with alcoholic liver disease: role of red cell ferritin. (1988) (14)
Mutant L-chain ferritins that cause neuroferritinopathy alter ferritin functionality and iron permeability. (2019) (14)
Properties of ferritin from the earthworm Octolasium complanatum (1984) (14)
Human ferritin H‐chains can be obtained in non‐assembled stable forms which have ferroxidase activity (1993) (14)
Analysis of the length distribution of amyloid fibrils by centrifugal sedimentation. (2016) (14)
Experimental determination of the frequency and field dependence of Specific Loss Power in Magnetic Fluid Hyperthermia (2017) (14)
Contribution of Electrostatics in the Fibril Stability of a Model Ionic-Complementary Peptide. (2015) (13)
Antibodies for denatured human H‐ferritin stain only reticuloendothelial cells within the bone marrow (1992) (13)
Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice (2019) (13)
Zirconia-doped nanoparticles: organic coating, polymeric entrapment and application as dual-imaging agents. (2013) (13)
A Colloidal Description of Intermolecular Interactions Driving Fibril-Fibril Aggregation of a Model Amphiphilic Peptide. (2015) (13)
Sequence variations in mitochondrial ferritin: distribution in healthy controls and different types of patients. (2010) (13)
Regional and cellular distribution of mitochondrial ferritin in the mouse brain (2010) (13)
Establishment of a scalable microfluidic assay for characterization of population‐based neutrophil chemotaxis (2020) (13)
Mitochondrial ferritin deficiency reduces male fertility in mice. (2017) (13)
Effect of cell proliferation on H-ferritin receptor expression in human T lymphoid (MOLT-4) cells. (1992) (12)
Adaptive chemo-enzymatic microreactors composed of inorganic nanoparticles and bio-inspired intrinsically disordered proteins. (2020) (12)
A Nanoparticle-based Assay to evaluate Surface-Induced Antibody Instability. (2020) (12)
Design and site-directed compartmentalization of gold nanoclusters within the intrasubunit interfaces of ferritin nanocage (2019) (12)
Programmable Zwitterionic Droplets as Biomolecular Sorters and Model of Membraneless Organelles (2021) (12)
Relationship of PEG-induced Precipitation with Protein-Protein Interactions and Aggregation Rates of High Concentration mAb Formulations at 5 °C. (2020) (11)
Intermittent contact mode AFM investigation of native plasma membrane of Xenopus laevis oocyte (2009) (11)
Effect of primary particle morphology on the structure of gels formed in intense turbulent shear. (2010) (11)
Phonon-induced relaxation in the Cr7Ni magnetic molecule probed by NMR (2010) (11)
A site-specific intraoperative measurement of bone-to-implant contact during implant insertion: A study on bovine ribs using a computerized implant motor (2015) (11)
Immunohistochemistry of HFE in the duodenum of C282Y homozygotes with antisera for recombinant HFE protein. (2000) (11)
Correlation Between Bone Density and Instantaneous Torque at Implant Site Preparation: A Validation on Polyurethane Foam Blocks of a Device Assessing Density of Jawbones. (2016) (11)
Sinus augmentation and concomitant implant placement in low bone‐density sites. A retrospective study on an undersized drilling protocol and primary stability (2018) (11)
Characteristics and expression of binding sites specific for ferritin H- chain on human cell lines (1988) (11)
Selective crystallization of horse isoferritins. (1983) (11)
Sequestration within biomolecular condensates inhibits Aβ-42 amyloid formation† (2021) (11)
Design of Biopharmaceutical Formulations Accelerated by Machine Learning. (2021) (11)
Use of a reference standard to improve the accuracy and precision of seven kits for determination of ferritin in serum. (1984) (11)
PEGylated Anionic Magnetofluorescent Nanoassemblies: Impact of Their Interface Structure on Magnetic Resonance Imaging Contrast and Cellular Uptake. (2017) (10)
Transcranial in vivo detection of amyloid-beta at single plaque resolution with large-field multifocal illumination fluorescence microscopy (2020) (10)
Local spin dynamics of iron oxide magnetic nanoparticles dispersed in different solvents with variable size and shape: A 1H NMR study. (2017) (10)
Effect of surfactants on shear-induced gelation and gel morphology of soft strawberry-like particles. (2011) (10)
Coexistence of steady state and transient state in isoelectric focusing (1978) (10)
Rapid Characterization and Quantification of Extracellular Vesicles by Fluorescence‐Based Microfluidic Diffusion Sizing (2021) (10)
Observing Xenopus laevis oocyte plasma membrane by Atomic Force Microscopy. (2010) (10)
New signaling pathways for hepcidin regulation. (2014) (10)
A possible novel objective intraoperative measurement of maxillary bone density. (2013) (10)
Iron as Therapeutic Target in Human Diseases (2019) (9)
Novel Functional Changes during Podocyte Differentiation: Increase of Oxidative Resistance and H-Ferritin Expression (2014) (9)
Precipitation Copolymerization of Vinyl-Imidazole and Vinyl-Pyrrolidone, 1 – Experimental Analysis (2011) (9)
Non-specificity as the sticky problem in therapeutic antibody development (2022) (9)
Broad-Band Spectrum, High-Sensitivity Absorbance Spectroscopy in Picoliter Volumes. (2021) (9)
Stereocontrolled synthesis of hydroxyethylamine isosteres via chiral sulfoxide chemistry (2004) (9)
Precipitation Copolymerization of Vinyl-imidazole and Vinyl-pyrrolidone, 2 – Kinetic Model† (2011) (9)
A torque-measuring micromotor provides operator independent measurements marking four different density areas in maxillae (2015) (9)
Energetics of surface confined ferritin during iron loading. (2016) (9)
Analysis of Nucleotide Variations in Genes of Iron Management in Patients of Parkinson's Disease and Other Movement Disorders (2010) (9)
The binding of the small heat-shock protein αB-crystallin to fibrils of α-synuclein is driven by entropic forces (2021) (9)
Elongated magnetic nanoparticles with high-aspect ratio: a nuclear relaxation and specific absorption rate investigation. (2019) (9)
A Counter Propagating Lens-Mirror System for Ultrahigh Throughput Single Droplet Detection. (2020) (8)
Pat 1 promotes processing body assembly by enhancing the phase separation of the DEAD-box ATPase Dhh 1 and RNA (2019) (8)
Preventing peptide and protein misbehavior (2015) (8)
The role of heparin, heparanase and heparan sulfates in hepcidin regulation. (2019) (8)
Measurement of Ferritin-Bearing Lymphocytes in Man. Preliminary Studies on the Use of Monoclonal Antibodies Specific for the L and H Subunits of Ferritin (1987) (8)
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. (2007) (8)
Mitochondrial Ferritin Expression and Clonality of Hematopoiesis in Patients with Refractory Anemia with Ringed Sideroblasts. (2005) (8)
Ferritin exhibits Michaelis-Menten behavior with oxygen but not with iron during iron oxidation and core mineralization. (2019) (8)
Interactions of succinate dehydrogenase with cyanide. (1973) (8)
Double-Layer Fatty Acid Nanoparticles as a Multiplatform for Diagnostics and Therapy (2022) (8)
Thermodynamic and Kinetic Studies of the Nuclear Receptor Coactivator-4 (NCOA4) Interaction with Human Ferritin. (2020) (8)
H and L ferritins in myocardium in iron overload. (1991) (8)
Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice (2022) (8)
A new catechol-functionalized polyamidoamine as an effective SPION stabilizer. (2019) (8)
Cooperative Assembly of Hsp70 Subdomain Clusters (2018) (7)
The association between low skeletal muscle mass and delirium: results from the nationwide multi-centre Italian Delirium Day 2017 (2021) (7)
Production and characterization of functional recombinant hybrid heteropolymers of camel hepcidin and human ferritin H and L chains (2017) (7)
Antiferritin VL homodimer binds human spleen ferritin with high specificity. (2002) (7)
Pentosan Polysulfate to control hepcidin expression in vitro and in vivo. (2020) (7)
Insights on the (Auto)Photocatalysis of Ferritin. (2016) (7)
Analysis of the iron status of professional cyclists during a 3-week road race. (1988) (7)
MR imaging and targeting of human breast cancer cells with folate decorated nanoparticles (2015) (7)
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells (2019) (7)
An ELISA for the H-Subunit of Human Ferritin which Employs a Combination of Rabbit Poly- and Mice Monoclonal Antibodies and an Enzyme Labeled Anti-Mouse-IgG (1999) (7)
Electrophoretic analysis of horse tissue ferritins at different pH values. (1980) (7)
The effect of undersizing and tapping on bone to implant contact and implant primary stability: A histomorphometric study on bovine ribs (2018) (7)
Sensitivity analysis of the variability of amyloid aggregation profiles. (2019) (7)
Ferritin in Human Milk (1984) (7)
SPIO@SiO2–Re@PEG nanoparticles as magneto-optical dual probes and sensitizers for photodynamic therapy (2016) (6)
Structural and immunologic relationships of human isoferritins in normal and disease states. (1976) (6)
The interface of condensates of the hnRNPA1 low complexity domain promotes formation of amyloid fibrils (2022) (6)
Ferritins: Structural and Functional Aspects (2002) (6)
Crystallographic data for horse heart ferritin (1984) (6)
Author Correction: Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide (2020) (6)
Structural studies on recombinant human ferritins. (1990) (6)
How Xylenol Orange and Ferrous Ammonium Sulphate Influence the Dosimetric Properties of PVA–GTA Fricke Gel Dosimeters: A Spectrophotometric Study (2022) (6)
Particle-based simulations of steady-state mass transport at high P\'eclet numbers (2015) (6)
Coating Effect on the 1H—NMR Relaxation Properties of Iron Oxide Magnetic Nanoparticles (2020) (5)
Magnetism and spin dynamics of novel encapsulated iron oxide superparamagnetic nanoparticles. (2013) (5)
Multifunctional Nanovectors Based on Polyamidoamine Polymers for Theranostic Application. (2019) (5)
Ferritin in glioblastoma (2020) (5)
A Novel Approach for the Synthesis of Human Heteropolymer Ferritins of Different H to L Subunit Ratios. (2021) (5)
Actions of H-subunit ferritin and lactoferrin as suppressor molecules of myelopoiesis in vitro and in vivo. (1991) (5)
Dynamics of Synthetic Membraneless Organelles in Microfluidic Droplets (2019) (5)
Dynamics and Control of Peptide Self-Assembly and Aggregation. (2019) (5)
Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis. (2020) (5)
Implant Diameter, Length, and the Insertion Torque/Depth Integral: A Study Using Polyurethane Foam Blocks (2020) (5)
Magnetic stimulation of gold fiducial markers used in Image-Guided Radiation Therapy: Evidences of hyperthermia effects (2020) (5)
Recombinant overexpression of camel hepcidin cDNA in Pichia pastoris: purification and characterization of the polyHis‐tagged peptide HepcD‐His (2017) (5)
Dipolar ordering in a molecular nanomagnet detected using muon spin relaxation (2014) (5)
Iron Mobilization from Ferritin in Yeast Cell Lysate and Physiological Implications (2022) (5)
A Molecular Logic Gate Enables Single-Molecule Imaging and Tracking of Lipids in Intracellular Domains. (2020) (5)
Surface-induced protein aggregation and particle formation in biologics: current understanding of mechanisms, detection and mitigation strategies. (2022) (4)
Bone Density and Implant Primary Stability. A Study on Equine Bone Blocks (2019) (4)
Modeling the Structure and Interactions of Intrinsically Disordered Peptides with Multiple Replica, Metadynamics-Based Sampling Methods and Force-Field Combinations (2021) (4)
Electron Spin Resonance and Atomic Force Microscopy Study on Gadolinium Doped Ceria (2015) (4)
Modeling of Continuous PHA Production by a Hybrid Approach Based on First Principles and Machine Learning (2021) (4)
Role of urea on recombinant Apo A-I stability and its utilization in anion exchange chromatography. (2014) (4)
Chemico-physical and functional differences between H and L chains of human ferritin. (1994) (4)
BMP6 binding to heparin and heparan sulfate is mediated by N-terminal and C-terminal clustered basic residues. (2020) (4)
Systematic Development of Small Molecules to Inhibit Specific Microscopic Steps of Amyloid-Beta42 Aggregation in Alzheimer's Disease (2018) (4)
Direct observation of human liver ferritin by scanning tunneling microscopy (1994) (4)
Chemically and biologically harmless versus harmful ferritin/copper-metallothionein couples. (2015) (4)
Gel filtration analysis of equine ferritin subunits (1979) (4)
Photoacoustic molecular imaging for in vivo liver iron quantitation (2016) (3)
Adaptive Chemoenzymatic Microreactors Composed of Inorganic Nanoparticles and Bioinspired Intrinsically Disordered Proteins (2020) (3)
Transferrin receptor 2 and HFE regulate furin expression via MAPK/Erk signalling. Implications for transferrin-dependent hepcidin regulation Running Title: TfR2 and HFE regulate furin expression (2010) (3)
Iron oxidation in sheep, horse and recombinant human apoferritins. (1994) (3)
Cortical Thickness, Bone Density, and the Insertion Torque/Depth Integral: A Study Using Polyurethane Foam Blocks. (2021) (3)
Magnetization and spin dynamics of a Cr-based magnetic cluster:Cr7Ni (2008) (3)
Low-field spin dynamics of Cr7Ni and Cr7Ni-Cu-Cr7Ni molecular rings as detected by μsR (2017) (3)
Nucleation in protein aggregation in biotherapeutic development: a look into the heart of the event. (2022) (3)
Stability of Dental Implants and Thickness of Cortical Bone: Clinical Research and Future Perspectives. A Systematic Review (2021) (3)
Muon spin relaxation investigation of tetranuclear iron(III) Fe4 (OCH3) 6 (dpm) 6 molecular cluster (2009) (3)
Effect of Phosphate and Ferritin Subunit Composition on the Kinetics, Structure, and Reactivity of the Iron Core in Human Homo- and Heteropolymer Ferritins. (2022) (3)
Stability and aggregation kinetics of colloidal systems: application to polymer colloids, proteins and peptides (2011) (3)
Relative contribution of iron genes, dysmetabolism and hcv in the pathogenesis of altered iron regulation in chronic hepatitis C (2007) (2)
Effect of Spin Clustering on Basic and Relaxometric Properties of Magnetic Nanoparticles. (2019) (2)
Conjugation of a GM3 lactone mimetic on carbon nanotubes enhances the related inhibition of melanoma-associated metastatic events. (2018) (2)
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties (2023) (2)
Thermodynamic and kinetic design principles for protein aggregation inhibitors (2020) (2)
NMR and μ+SR detection of unconventional spin dynamics in Er(trensal) and Dy(trensal) molecular magnets (2019) (2)
and erythroid progenitor cells subunit ferritins on colony formation in vitro by granulocyte- macrophage The influence of purified recombinant human heavy-subunit and light- (2011) (2)
Mamary Control of Iron Secretion in Milk a (1986) (2)
Local spin dynamics at low temperature in the slowly relaxing molecular chain [Dy(hfac)3{NIT(C6H4OPh)}]: A μ+ spin relaxation study (2015) (2)
An Intraoperative Site-specific Bone Density Device: A Pilot Test Case. (2015) (2)
Structure and immunochemistry of isoferritins. (1984) (2)
Transcranial detection of amyloid‐beta at single plaque resolution in vivo with large‐field multifocal illumination fluorescence microscopy (2020) (2)
Evaluation of Peri-implant Bone Stress on D1 Bone Using a Computerized Torque-Measuring Implant Motor: A Study on Photoelastic Resin Blocks. (2018) (2)
Optical reflectance apparatus for moisture content determination in porous media (2020) (2)
Ridge Preservation Using an Innovative Enzyme-deantigenic Equine Bone Paste: A Case Report with 36-month Follow-up. (2019) (2)
Applications and Properties of Magnetic Nanoparticles (2021) (2)
Management of transthyretin amyloidosis. (2021) (2)
Corrigendum: Dynamics of Synthetic Membraneless Organelles in Microfluidic Droplets. (2019) (1)
Front Cover: Acceleration of an Enzymatic Reaction in Liquid Phase Separated Compartments Based on Intrinsically Disordered Protein Domains (ChemSystemsChem 4/2020) (2020) (1)
Hyperthermostable recombinant human heteropolymer ferritin derived from a novel plasmid design (2022) (1)
Evaluation of heart isoferritins in serum using specific monoclonal antibodies (1984) (1)
Low field spin dynamics of Cr 7 Ni and Cr 7 NiCu-Cr 7 Ni molecular rings as detected by μ SR (2017) (1)
Berichtigung: Dynamics of Synthetic Membraneless Organelles in Microfluidic Droplets (2019) (1)
A Temperature-Controlled Stopped-Flow Droplet-Based Microfluidic Reactor for Fast Biomolecular Kinetics (2018) (1)
High-Yield Separation of Extracellular Vesicles Using Programmable Zwitterionic Coacervates. (2022) (1)
Recombinant overexpression of camel hepcidin cDNA in Pichia pastoris: purification and characterization of the polyHis‐tagged peptide HepcD‐His (2018) (1)
"Production, purification and aggregation of IgE lambda light chain fragment" (2010) (1)
Longitudinal and transverse NMR relaxivities of Ln(III)-DOTA complexes: a comprehensive investigation (2021) (1)
Droplet Microfluidics for the Label-Free Extraction of Complete Phase Diagrams and Kinetics of Liquid-Liquid Phase Separation in Finite Volumes. (2022) (1)
Characterization of the H and L Subunit Ratios of Ferritins by SDS Capillary Gel Electrophoresis (2002) (1)
Droplet-Based Microfluidic Temperature-Jump Platform for the Rapid Assessment of Biomolecular Kinetics. (2022) (1)
Biophysical Aspects of Alzheimer’s Disease: Implications for Pharmaceutical Sciences (2017) (1)
Multi-instrumental characterization of porous media: the role of the Spilling Drop Test (2020) (1)
Low-temperature anomalies in muon spin relaxation of solid and hollowγ−Fe2O3nanoparticles: A pathway to detect unusual local spin dynamics (2020) (1)
Cellular binding analysis of recombinant hybrid heteropolymer of camel hepcidin and human ferritin H chain. The unexpected human H-ferritin binding to J774 murine macrophage cells (2019) (1)
Ferritin/ferroxidase activity: A potent inhibitor of vascular calcification, osteoblastic transdifferentiation of vascular smooth muscle cells and osteoblast activity (2012) (1)
causes an iron-deficient phenotype with mitochondrial iron overload RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells (2009) (1)
Aggregation Mechanism of an IgG2 and two IgG1 Monoclonal Antibodies at low pH: From Oligomers to Larger Aggregates (2012) (0)
A fibronectin type III fold in plant allergens: The solution structure of Phl PII from timothy grass pollen, NMR, 38 STRUCTURES (1999) (0)
Inside Cover: Adaptive Chemoenzymatic Microreactors Composed of Inorganic Nanoparticles and Bioinspired Intrinsically Disordered Proteins (Angew. Chem. Int. Ed. 21/2020) (2020) (0)
Correction: Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice. (2020) (0)
Crystal structure of human ferritin FTL498InsTC pathogenic mutant (2010) (0)
The effect of chemico-physical parameters of magnetic nanoparticles on their fundamental and biomedical applicative properties: a few case studies (2018) (0)
Breast cancer cell's lipid rafts modifications by n-3 polyunsaturated fatty acids (2010) (0)
Fe3O4@SiO2-Re-PEG nanoparticles as magneto-optical dual probes and new PDT agents (2016) (0)
A nanoparticle platform for accelerated surface-mediated assays of protein stability (2018) (0)
Biology of ferritin in mammals: an update on iron storage, oxidative damage and neurodegeneration (2014) (0)
Crystallization and preliminary X-ray diffraction data of mouse L-chain apoferritin crystals. (2000) (0)
Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity (2014) (0)
Silencing of ABCB7 in HeLa cells causes an iron deficient phenotype and mitochondrial iron overload. (2006) (0)
Crystal Structure of L-Chain Mouse Ferritin at 1.2 Å resolution (2000) (0)
(acidic) ferritin on murine myelopoiesis Suppressive effects in vivo of purified recombinant human H-subunit (2011) (0)
Structure and morphology of polymer clay nanocomposites: the contribution of X-ray diffraction (2007) (0)
The effect of size, shape, coating and functionalization on nuclear relaxation properties in iron oxide core-shell nanoparticles: a brief review of the situation. (2023) (0)
A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes (2021) (0)
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity (2012) (0)
Ferritin nanocages as efficient nanocarriers and promising platforms for COVID-19 and other vaccines development (2022) (0)
Hyperthermic and Relaxometric Properties of Cobalt Ferrite Nanoparticles (2021) (0)
Study of ferritin self-assembly and heteropolymer formation using FRET (2017) (0)
Phenotypes and Specific Mutations in the Iron-Responsive Element of Hereditary Hyperferritinemia-Cataract Syndrome: Relationship Between (2013) (0)
Biochemical and biophysical approaches to study the incorporation of omega-3 LCPUFA on breast cancer cells lipid rafts (2011) (0)
A novel three-step immunoscintigraphy employing an anti-ferritin antibody to detect hepatocellular carcinoma (1995) (0)
Iron as Therapeutic Targets in Human Diseases Volume 1 (2020) (0)
recombinant mouse L-chain ferritin (2001) (0)
Back Cover Picture: Biotechnology Journal 10/2019 (2019) (0)
Hyperthermia properties of fiducial markers used in Image-Guided Radiation Therapy at Low Magnetic Fields (2017) (0)
Microfluidic diffusion analysis of the size distribution and micro-rheological properties of antibody solutions at high concentrations (2018) (0)
cell growth control modulation during cellular proliferation and potential implication in Specific binding sites for H-ferritin on human lymphocytes: (2011) (0)
Chemical–Physical Changes in Cell Membrane Microdomains of Breast Cancer Cells After Omega-3 PUFA Incorporation (2012) (0)
Effects of DHA incorporation in membrane lipid rafts of MDA-MB-231 human breast cancer cells (2011) (0)
A conserved mechanism regulates reversible amyloids via pH-sensing regions (2022) (0)
DHPLC Scan of Iron Genes in Consecutive Patients with Suspected Iron Overload. (2004) (0)
L-ferritin transfection with siRNAs and cDNAs: evidence for a proliferative role of Analysis of the biologic functions of H- and L-ferritins in HeLa cells by (2010) (0)
Crystallographic studies on horse isoferritins (1983) (0)
Distribution of trabecular bone density in the maxilla and mandible (2019) (0)
PL-25 - Role of heme in soft tissue mineralization (2016) (0)
pathophysiologic conditions (2018) (0)
LOL pII Allergen (1996) (0)
P-37 Flow cytometric analysis of cytosolic and mitochondrial ferritins in immature red blood cells from patients with myelodysplastic syndrome (2005) (0)
pathogenetic mechanism in juvenile hemochromatosis Defective targeting of hemojuvelin to plasma membrane is a common (2012) (0)
Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments (2021) (0)
VARIABLE LIGHT CHAIN DIMER OF ANTI-FERRITIN ANTIBODY (2002) (0)
Dosimetric Double Network Hydrogel Based on Poly(vinyl-alcohol)/Phenylalanine-Derivatives with Enhanced Mechanical Properties (2023) (0)
[Determination of human serum ferritin by latex immunoassay]. (1984) (0)
Stereocontrolled Synthesis of Hydroxyethylamine Isosteres via Chiral Sulfoxide Chemistry. (2004) (0)
granulocyte-monocyte progenitors Effect of acidic and basic isoferritins on in vitro growth of human (2011) (0)
Nanosized T1 MRI Contrast Agent Based on a Polyamidoamine as Multidentate Gd Ligand (2021) (0)
Iron Oxide-PNA nanoparticles for miRNA targeting (2015) (0)
Mechanisms of Ferritin Iron Incorporation: A Study with Recombinant and Mutant Human Ferritins (1991) (0)
Microfluidic and nanotechnology based assays for the development of safe biopharmaceuticals (2019) (0)
Lol pII allergen. Production and characterization of the recombinant protein and human antibody fragments. (1996) (0)
Atomic Force Microscopy study of lipid rafts in MDA-MB-231 human breast cancer cells after DHA incorporation (2011) (0)
High‐Yield Production of Extracellular Vesicle Subpopulations with Constant Quality Using Batch‐Refeed Cultures (2022) (0)
Biochemical, Biophysical and Functional Characterization of an Insoluble Iron Containing Hepcidin–Ferritin Chimeric Monomer Assembled Together with Human Ferritin H/L Chains at Different Molar Ratios (2021) (0)
Structure of a human mitochondrial ferritin at 1.7 Å resolution (2002) (0)
Insights into the Inhibition Mechanism of Biomolecular Self-Assembly from Chemical Kinetics (2014) (0)
2020 Reviewer Thanks (2021) (0)
Ferritin in glioblastoma (2020) (0)
Hemosiderin in hemochromatotic liver is mainly derived from denatured H-ferritin subunit (2000) (0)
No Job Name (1998) (0)
Targeting the Formation of Amyloid Oligomers using Rationally Designed Antibodies (2019) (0)
dendritic cells Heavy chain ferritin activates regulatory T cells by induction of changes in (2013) (0)
α-Synuclein Aggregation is Triggered by Amyloid-β Oligomers via Heterogeneous Primary Nucleation (2023) (0)
Dynamic renormalisation group reveals sequential mechanism of the secondary nucleation of proteins (2014) (0)
Fe3O4@PNA nanoconjugates for miRNA dysregulation (2015) (0)
Thermography for hyperthermia effects visualisation during magnetic stimulation in Image-Guided Radiation Therapy (2020) (0)
Objective metrics for language lateralization of fMRI examinations: a new model for the classification of hemispheric dominance in healthy subjects and epileptic patients (2021) (0)
Biophysical Aspects of Alzheimer’s Disease: Implications for Pharmaceutical Sciences (2017) (0)
Analytical Use of Antibodies Based on Specific Molecular Binding (1987) (0)
IN VIVO OPTOACOUSTIC TOMOGRAPHY OF BRAIN AMYLOID DEPOSITS IN AN ARCAβ MOUSE MODEL OF ALZHEIMER’S DISEASE (2018) (0)
A Molecular Logic Gate Enables Super-Resolved Imaging of Intracellular Lipid Droplets (2019) (0)
EFFECT OF SUCROSOMIAL (R) IRON IN A IRON DEFICIENCY ANEMIA MOUSE MODEL (2017) (0)
tic iron oxide nanoparticles functionalized by peptide nucleic acids † (2017) (0)
OBJECTIVE METRIC FOR ASSESSMENT OF LANGUAGE LATERALIZATION IN HEALTHY SUBJECTS AND EPILEPTIC PATIENTS (2022) (0)
Back Cover Image, Volume 117, Number 2, February 2020 (2020) (0)
Engineering Aspects of Protein Interactions and Self-assembly. (2018) (0)
Investigation of Natural and Synthetic Aggregation Inhibitors using Microfluidic Applications (2020) (0)
AVIDIN MUTANT (K3E,K9E,R26D,R124L) (1998) (0)
Innentitelbild: Adaptive Chemoenzymatic Microreactors Composed of Inorganic Nanoparticles and Bioinspired Intrinsically Disordered Proteins (Angew. Chem. 21/2020) (2020) (0)
Proton Therapy, Magnetic Nanoparticles and Hyperthermia as Combined Treatment for Pancreatic BxPC3 Tumor Cells (2023) (0)
Characterization of PVA-GTA Fricke gels dosimeters using MRI and optical techniques in X-rays external radiation therapy (2020) (0)
The Use of Ferritin as a Carrier of Peptides and Its Application for Hepcidin (2020) (0)
TARGETING AMYLOID FORMATION USING RATIONALLY DESIGNED ANTIBODIES (2018) (0)
Improving extracellular vesicles production through a Bayesian optimization-based experimental design. (2022) (0)
Mechanism of Adsorption of Anionic Surfactants on the Surface of Functionalized Nanoparticles (2008) (0)
crystal structure of a human mitochondrial ferritin (2004) (0)
Magnetic nanoparticles: the effect of chemico-physical parameters on their fundamental and biomedical applicative properties (2018) (0)
Silencing of pantothenate Kinase-2 (Pank2) in HeLa cells causes alterations of iron homeostasis that are partially reverted by the expression of mitochondrial ferritin. (2008) (0)
New Advances in Iron Metabolism, Ferritin and Hepcidin Research (2022) (0)
Single Droplet Detection: A Counter Propagating Lens‐Mirror System for Ultrahigh Throughput Single Droplet Detection (Small 20/2020) (2020) (0)
Correction: Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice. (2020) (0)
Cellular binding analysis of recombinant hybrid heteropolymer of camel hepcidin and human ferritin H chain. The unexpected human H-ferritin binding to J774 murine macrophage cells (2019) (0)
Session I BASIC ASPECTS OF IRON BIOLOGY (2014) (0)
Erastin is a strong inducer of ferroptosis in human rhabdomyosarcoma cell lines (2016) (0)
1H-NMR Relaxation of Ferrite Core-Shell Nanoparticles: Evaluation of the Coating Effect (2023) (0)
Chemical-physical changes in breast cancer lipid rafts after omega-3 PUFA incorporation (2010) (0)
AF4 and PEG Precipitation as Predictive Assays for Antibody Self-Association. (2023) (0)
Comparative Studies of the Superparamagnetic Properties of Engineered H-rich and L-rich Human Ferritins Reconstituted with 500 57 Fe-atoms / Protein (2018) (0)
Ferritin Heavy Chain Stimulates HbS-to-HbF Switching in Erythroid Precursor Cells from Sickle Cell Patients. (2006) (0)
Protein Phase Transition: From Biology Towards New Protein Materials (2019) (0)
Mechanisms of Amyloid-beta 42 oligomer formation from kinetic analysis (2017) (0)
261. Hyperthermia properties of gold fiducial markers (2018) (0)
IMMUNOSUPPRESSIV EEFFECT SO FMELANOMA-DERIVE DHEAVY-CHAIN FERRITI NAR EDEPENDEN TO NSTIMULATIO NO FIL-1 0PRODUCTION (2001) (0)
μSR investigation of spin dynamics in pure and Zn-doped Co(hfac)2NITPhOMe single-chain magnet (2008) (0)
Structure of recombinant mouse L chain ferritin at 1.2 A resolution (2003) (0)
Measuring Self-Association of Antibody Lead Candidates with Dynamic Light Scattering. (0)
Iron biomineral core structure of in vitro reconstituted human ferritins overexpressed in E-coli: A M\"{o}ssbauer investigation. (2016) (0)
Stability and functionality of HL heteropolymer ferritins responsible for a hereditary ferritinopathy disorder (2012) (0)
Recent Developments in the Use of Magnetic Fluid Hyperthermia on Glioblastoma Multiforme Disease (2021) (0)
Iron as Therapeutic Targets in Human Diseases Volume 2 (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paolo Arosio?

Paolo Arosio is affiliated with the following schools:

Paolo Arosio's Academic­Influence.com Rankings

Paolo Arosio's Degrees

Similar Degrees You Can Earn

Why Is Paolo Arosio Influential?

Paolo Arosio's Published Works

Published Works

What Schools Are Affiliated With Paolo Arosio?

Paolo Arosio's AcademicInfluence.com Rankings